Neurostimulator Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-04-01　·　151 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 10.4 Bn
2033 年預估規模: USD 19.8 Bn
年複合成長率 CAGR: 9.63%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Neurostimulator Market, By Product Type (Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Gastric Electrical Stimulators, and Transcutaneous Electrical Nerve Stimulators), By Technology (Implantable Neurostimulators and External Neurostimulators), By Application (Chronic Pain Management, Parkinsons Disease, Epilepsy, Depression, Urinary and Fecal Incontinence, and Gastroparesis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), and Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

The global neurostimulator market is estimated to be valued at USD 10.4 Bn in 2026 and is expected to reach USD 19.8 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 9.63% from 2026 to 2033. The global neurostimulator market is a significant segment in the field of medical devices. This market is dominated by advanced technologies that can deliver controlled electrical impulses for stimulating neural activities. The various types of neurostimulators include spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, and peripheral nerve stimulators. These types of neurostimulators are used to treat chronic pain, epilepsy, Parkinson's disease, depression, and other medical problems. These neurostimulators are either implantable or external types of devices. These devices can be simple or advanced multi-electrode types that can deliver advanced programming for effective therapy. The improvement in battery technology, wireless technology, closed-loop technology, and biocompatibility is making this technology more user-friendly. More and more people are becoming aware of this technology and its uses. This is making the global neurostimulator market grow at a high rate because this is an effective and cost-friendly solution for conventional treatments. Market Dynamics The major driver for the global neurostimulator market is the rising prevalence of neurological disorders, chronic pain syndromes, and treatment-resistant depression. This creates a large unmet need in the medical community. In addition, the rising age of the population also contributes to the growing prevalence of various neurodegenerative disorders and movement disorders. This increases the market size. In addition to this, growing awareness among healthcare providers about the clinical efficacy and cost-effectiveness of neurostimulation versus pharmaceutical management is also driving this market. The technological changes have also played a significant role in the growth of the market. In this context, it has to be mentioned that the technological advances in the form of miniaturization, longer battery life, wireless connectivity, and closed-loop stimulation have helped in the improvement of the devices. The challenges faced by the market are the high cost of devices, regulatory challenges, and the lack of reimbursements. In addition, the technological challenges, including the reliability of the devices, battery life, and the possibility of complications such as infection and lead migration, have also posed challenges to the market. However, the market also offers significant opportunities for growth in terms of clinical application expansion in areas such as mental health disorders and other emerging areas. In terms of minimally invasive implantation technology advancements and the development of non-invasive neurostimulation products, the market is expanding the scope of patients who can be treated with neurostimulators. Improving healthcare infrastructure in emerging markets and the development of medical tourism are also offering opportunities for the expansion of the neurostimulator market. Key Features of the Study • This report provides in-depth analysis of the global neurostimulator market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global neurostimulator market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Medtronic, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Nevro Corp, Integer Holdings Corporation, Synapse Biomedical Inc, NeuroPace Inc, Aleva Neurotherapeutics, and Nalu Medical Inc • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global neurostimulator market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurostimulator market Market Segmentation • Product Type Insights (Revenue, USD Bn, 2021 - 2033) o Spinal Cord Stimulators o Deep Brain Stimulators o Vagus Nerve Stimulators o Sacral Nerve Stimulators o Gastric Electrical Stimulators o Transcutaneous Electrical Nerve Stimulators • Technology Insights (Revenue, USD Bn, 2021 - 2033) o Implantable Neurostimulators o External Neurostimulators • Application Insights (Revenue, USD Bn, 2021 - 2033) o Chronic Pain Management o Parkinson’s Disease o Epilepsy o Depression o Urinary and Fecal Incontinence o Gastroparesis • End User Insights (Revenue, USD Bn, 2021 - 2033) o Hospitals o Specialty Clinics o Ambulatory Surgical Centers (ASCs) o Research Institutes • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Medtronic o Abbott Laboratories o Boston Scientific Corporation o LivaNova PLC o Nevro Corp o Integer Holdings Corporation o Synapse Biomedical Inc o NeuroPace Inc o Aleva Neurotherapeutics o Nalu Medical Inc

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Neurostimulator Market, By Product Type  Global Neurostimulator Market, By Technology  Global Neurostimulator Market, By Application  Global Neurostimulator Market, By End User  Global Neurostimulator Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Global Neurostimulator Market, By Product Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Spinal Cord Stimulators  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Deep Brain Stimulators  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Vagus Nerve Stimulators  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Sacral Nerve Stimulators  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Gastric Electrical Stimulators  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Transcutaneous Electrical Nerve Stimulators  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Neurostimulator Market, By Technology, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Implantable Neurostimulators  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o External Neurostimulators  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Neurostimulator Market, By Application, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Chronic Pain Management  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Parkinson's Disease  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Epilepsy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Depression  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Urinary and Fecal Incontinence  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Gastroparesis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Neurostimulator Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Specialty Clinics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Ambulatory Surgical Centers (ASCs)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Research Institutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Neurostimulator Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 9. Competitive Landscape o Medtronic  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Abbott Laboratories  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Boston Scientific Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o LivaNova PLC  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Nevro Corp  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Integer Holdings Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Synapse Biomedical Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o NeuroPace Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Aleva Neurotherapeutics  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Nalu Medical Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 10. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 11. References and Research Methodology o References o Research Methodology o About us Browse 32 market data tables and 28 figures on 'Neurostimulator Market' - Global forecast to 2033

提及公司

MedtronicAbbott LaboratoriesBoston Scientific CorporationLivaNova PLCNevro CorpInteger Holdings CorporationSynapse Biomedical IncNeuroPace IncAleva NeurotherapeuticsNalu Medical Inc

同分類最新報告（醫療器材）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們